PANCREATIC DUCTAL CARCINOMA
Clinical trials for PANCREATIC DUCTAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC DUCTAL CARCINOMA trials appear
Sign up with your email to follow new studies for PANCREATIC DUCTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill shows promise against tough cancers in early trial
Disease control CompletedThis early-phase study tested a new daily pill called JAB-3312 in 40 adults with advanced solid tumors (like lung, colorectal, or breast cancer) that had stopped responding to standard treatments. The main goals were to find the safest dose and check for side effects. Researchers…
Matched conditions: PANCREATIC DUCTAL CARCINOMA
Phase: PHASE1 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New drug combo tested for tough cancers
Disease control CompletedThis early-phase study tested a combination of two experimental drugs (vobramitamab duocarmazine and lorigerlimab) in 31 people with advanced solid tumors like prostate, melanoma, and pancreatic cancer. The main goal was to check safety and find the right dose. Participants recei…
Matched conditions: PANCREATIC DUCTAL CARCINOMA
Phase: PHASE1 • Sponsor: MacroGenics • Aim: Disease control
Last updated May 18, 2026 12:13 UTC